Nurix Therapeutics Inc (NRIX)

Operating Cash Flow (Statement)

$615.63M

Quarterly · Period ending: · USD

NRIX logo

NRIX Operating Cash Flow (Statement)

Latest reported$615.63M
NRIX Quarterly Cash from Operations (-$9.68M → $615.63M)
High-resolution chart · PNG

NRIX operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Nurix Therapeutics Inc Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
615,631,000
-96,573,000
-71,914,000
-67,832,000
-57,385,000
-63,161,000
-61,087,000
-48,751,000
-42,177,000
-39,705,000
-41,951,000
26,689,000
-41,133,000
-18,469,000
-48,452,000
-37,955,000
-46,308,000
-32,914,000
-42,630,000
-30,911,000
-29,972,000
-31,535,000
8,053,000
-20,482,000
-6,141,000
-14,429,000
40,972,000
-12,748,000
36,372,000
-13,341,000
-9,682,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.